Paper66871
Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary report.
Iwarson S and 6 others. Am J Med Sci, 1975. Cited by 21 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary report. Papers, record 66871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/66871
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staff: a preliminary report.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Immunization, Passive | Major topic |
| Antibody Formation | |
| Hepatitis B Antibodies | |
| Hospital Departments | |
| Humans | |
| Kidney Transplantation | |
| Personnel, Hospital | |
| Renal Dialysis | |
| gamma-Globulins |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,973,017 | Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms. | Viruses | 2020 | https://conductscience.org/library/papers/31973017 | PubMed |
| 12,102,547 | Back to the future: antibody-based strategies for the treatment of infectious diseases. | Mol Biotechnol | 2002 | https://conductscience.org/library/papers/12102547 | PubMed |
| 822,594 | Viral hepatitis, type B. | Yale J Biol Med | 1976 | https://conductscience.org/library/papers/822594 | PubMed |
| 723,783 | Vaccine against hepatitis B--18 months prevention in a high risk setting. | Med Microbiol Immunol | 1978 | https://conductscience.org/library/papers/723783 | PubMed |
| 466,862 | Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/466862 | PubMed |
| 196,274 | Recent advances in the identification of hepatitis viruses. | Postgrad Med J | 1977 | https://conductscience.org/library/papers/196274 | PubMed |
| 85,514 | Failure of endoscopic transmission of hepatitis B. | Dig Dis Sci | 1979 | https://conductscience.org/library/papers/85514 | PubMed |
| 60,830 | Passive immunization against exposure to hepatitis B virus in the military: potential and possibilities. | Yale J Biol Med | 1976 | https://conductscience.org/library/papers/60830 | PubMed |
| 59,545 | The use of standard gamma globulin for the prevention of hepatitis B. | Am J Dig Dis | 1976 | https://conductscience.org/library/papers/59545 | PubMed |
| 59,544 | The case for not giving gamma globulin in all exposure to hepatitis B. | Am J Dig Dis | 1976 | https://conductscience.org/library/papers/59544 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/66871
GET https://conductscience.org/api/papers/v1/66871/authors